jurnalul român de psihofarmacologie romanian journal of ...
jurnalul român de psihofarmacologie romanian journal of ...
jurnalul român de psihofarmacologie romanian journal of ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
93. Klieser E, Lehmann E, Kinzler E, Wurthmann C, Heinrich K. Randomized, double-blind,<br />
controlled trial <strong>of</strong> risperidone versus clozapine in patients with chronic schizophrenia. J<br />
Clin Psychopharmacol 1995; 15(Suppl. 1):45-51.<br />
94. Klieser E, Strauss WH, Lemmer W. The tolerability and efficacy <strong>of</strong> the atypical neuroleptic<br />
remoxipri<strong>de</strong> compared with clozapine and haloperidol in acute schizophrenia. Acta<br />
Psychiatr Scand 1994; 380(Suppl.):68-73.<br />
95. Meyer-Lin<strong>de</strong>nbereg A, Gruppe H, Bauer U, Lis S, Krieger S, Gallh<strong>of</strong>er B. improvement <strong>of</strong><br />
cognitive function in schizophrenic patients receiving clozapine or zotepine: Results <strong>of</strong> a<br />
double-blind study. Pharmacopsychiatry 1997; 30:35-42.<br />
96. Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Erp LB, Baumann P. Risperidone<br />
versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind<br />
study. Am J Psychiatry 1998; 155:499-504.<br />
97. Azorin JM, Spiegel R, Remington G, Vanelle JM, Pere JJ, Giguere M, Bour<strong>de</strong>ix I. A<br />
double-blind comparative study <strong>of</strong> clozapine and risperidone in the management <strong>of</strong> severe<br />
chronic schizophrenia. Am J Psychiatry 2001; 158:1305-1313.<br />
98. Tollefson GD, Birkett MA, Kiesler GM, Wood AJ and Lilly Resistant Schizophrenia Study<br />
Group. Double-blind comparison <strong>of</strong> olanzapine versus clozapine in schizophrenic patients<br />
clinically eligible for treatment with clozapine. Biol Psychiatry 2001; 49:52-63.<br />
99. Henrich K, Klieser E, Lehman E, Kinzler E, Hruschka H. Risperidone versus clozapine in<br />
the treatment <strong>of</strong> schizophrenic patients with acute symptoms: A double-blind randomized<br />
trial. Neuropsychopharmacol Biol Psychiatry 1994; 18:129-137.<br />
100. Kane JM, Safferman AZ, Pollack S, Johns, C, Szymanski S, Kronig M, Lieberman JA.<br />
Clozapine, negative symptoms and extrapyramidal si<strong>de</strong> effects. J Clin Psychiatry 1994;<br />
55(Suppl. 9B):74-77.<br />
101. McGurk SR. The effects <strong>of</strong> clozapine on cognitive functioning in schizophrenia. J Clin<br />
Psychiatry 1999; 60(Suppl. 12):24-29.<br />
102. Umbricht DSG, Lieberman JA, Kane JM. The clinical efficacy <strong>of</strong> clozapine in the treatment<br />
<strong>of</strong> schizophrenia. Rev Contemp Pharmacother 1995; 6:165-186.<br />
103. Potkin SG, Fleming K, Jin Y, Gulasekaram B. Clozapine enhances neurocognition and<br />
clinical symptomatology more than standard neuroleptics. J Clin Psychopharmacol 2001;<br />
21:479-483.<br />
104. Meltzer HY, McGurk SR. The effect <strong>of</strong> clozapine, risperidone and olanzapine on cognitive<br />
function in schizophrenia. Schizophrenia Bull 1999; 25:233-255.<br />
105. Meltzer HY, Okyli G. Reduction <strong>of</strong> suicidality during clozapine treatment <strong>of</strong> neurolepticresistant<br />
schizophrenia: impact <strong>of</strong> risk benefit assessment. Am J Psychiatry 1995; 152:183-190.<br />
140
Change language